ADiTx Inc (ADTX): ADTX - announces they are buying a compa...

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	27
Posts	5124
Boards Moderated	0
Alias Born	01/27/2014

trickledownfacists

Re: None

Wednesday, 08/25/2021 2:17:18 PM

Wednesday, August 25, 2021 2:17:18 PM

ADTX - announces they are buying a company developing a covid pill in Europe…. are they buying AEZS?
Heeeellooo!?

https://seekingalpha.com/instablog/50857529-johnsoriaknows/5629528-aezs-developing-game-changing-covidminus-19-orally-available-vaccine-while-diversifying

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent ADTX News

Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-27 Reverse Stock Split Effective at the Open of Trading on May 18, 2026 • Business Wire • 05/14/2026 12:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2026 08:20:22 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/01/2026 08:35:47 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/23/2026 08:30:42 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/22/2026 04:15:21 AM
Dana-Farber Cancer Institute Study Demonstrates Predictive Value of Ignite Proteomics’ RPPA Platform for T-DXd (Enhertu®) Therapy in Metastatic Breast Cancer Patients • Business Wire • 04/20/2026 12:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/14/2026 12:00:13 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 04/11/2026 01:49:19 AM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 04/07/2026 08:02:58 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/03/2026 08:37:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 01:13:36 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 08:35:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 12:00:37 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/27/2026 09:02:12 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/24/2026 09:21:36 PM
Aditxt Subsidiary Ignite Proteomics Appoints Public Company Veteran Jeff Busch as Chief Executive Officer • Business Wire • 03/19/2026 12:15:00 PM
Aditxt Acquires Ignite Proteomics to Expand Precision Oncology Capabilities • IH Market News • 03/13/2026 03:36:37 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/13/2026 12:35:24 PM
Aditxt Acquires Ignite Proteomics to Address a Critical Challenge in Cancer Care: Optimizing Therapy Selection • Business Wire • 03/13/2026 12:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 01:30:35 PM
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-8 Reverse Stock Split Effective at the Open of Trading on March 9, 2026 • Business Wire • 03/05/2026 01:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2026 10:03:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2026 09:23:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/28/2026 01:00:52 PM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent ADTX News

More ADTX News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent ADTX News

Go Ad-Free